CoChat
Sign Up
Cited by 161

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Nanocarriers for targeted drug delivery

Shah, Afzal, Aftab, Saima, Nisar, Jan, Ashiq, Muhammad Naeem, Iftikhar, Faiza Jan·2021·Journal of Drug Delivery Science and Technology
DOI 10.1016/j.jddst.2021.102426
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jddst.2021.102426

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 115

  1. Wang, 2014, Automated modular synthesis of aptamer–drug conjugates for targeted drug delivery, J. Am. Chem. Soc., 136, 2731, 10.1021/ja4117395 · DOI
  2. Farooq, 2019, Nanocarrier-mediated co-delivery systems for lung cancer therapy: recent developments and prospects, Environ. Chem. Lett., 17, 1565, 10.1007/s10311-019-00897-7 · DOI
  3. Xia, 2014, Hydrophobic drug-triggered self-assembly of nanoparticles from silk-elastin-like protein polymers for drug delivery, Biomacromolecules, 15, 908, 10.1021/bm4017594 · DOI
  4. Jain, 2013, Targeted drug delivery to macrophages, Expet Opin. Drug Deliv., 10, 353, 10.1517/17425247.2013.751370 · DOI
  5. Patil, 2019, Nanotechnology derived nanotools in biomedical perspectives: an update, Curr. Nanosci., 15, 137, 10.2174/1573413714666180426112851 · DOI
  6. Mukherjee, 2019, Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives, Int. J. Nanomed., 14, 1937, 10.2147/IJN.S198353 · DOI
  7. Mirza, 2014, Nanomedicine and drug delivery: a mini review, Int. Nano Lett., 4, 94, 10.1007/s40089-014-0094-7 · DOI
  8. Lu, 2016, Recent progress on nanostructures for drug delivery applications, J. Nanomater., 2016, 5762431, 10.1155/2016/5762431 · DOI
  9. Zhang, 2021, Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver, Biomater. Sci.
  10. Swierczewska, 2016, Polysaccharide-based nanoparticles for theranostic nanomedicine, Adv. Drug Deliv. Rev., 99, 70, 10.1016/j.addr.2015.11.015 · DOI
  11. Yhee, 2014, Self-assembled glycol chitosan nanoparticles for disease-specific theranostics, J. Contr. Release, 193, 202, 10.1016/j.jconrel.2014.05.009 · DOI
  12. Banerjee, 2016, Role of nanoparticle size, shape and surface chemistry in oral drug delivery, J. Contr. Release, 238, 176, 10.1016/j.jconrel.2016.07.051 · DOI
  13. Steinbach, 2016, Cell penetrating peptide-modified poly (lactic-co-glycolic acid) nanoparticles with enhanced cell internalization, Acta Biomater., 30, 49, 10.1016/j.actbio.2015.11.029 · DOI
  14. Hu, 2015, Facile synthesis of RGD peptide-modified iron oxide nanoparticles with ultrahigh relaxivity for targeted MR imaging of tumors, Biomater. Sci., 3, 721, 10.1039/C5BM00037H · DOI
  15. Mahmoodi, 2016, A comparative study on the nanoparticles for improved drug delivery systems, J. Photochem. Photobiol. B Biol., 162, 681, 10.1016/j.jphotobiol.2016.07.037 · DOI
  16. Greineder, 2016, Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans, J. Contr. Release, 226, 229, 10.1016/j.jconrel.2016.02.006 · DOI
  17. Pisetpackdeekul, 2016, Proretinal nanoparticles: stability, release, efficacy, and irritation, Int. J. Nanomed., 11, 3277, 10.2147/IJN.S111748 · DOI
  18. Hooshyari, 2019, Advanced nanocomposite membranes based on sulfonated polyethersulfone: influence of nanoparticles on PEMFC performance, J. Iran. Chem. Soc., 16, 1617, 10.1007/s13738-019-01638-x · DOI
  19. Pan, 2013, High‐sensitivity real‐time analysis of nanoparticle toxicity in green fluorescent protein‐expressing zebrafish, Small, 9, 863, 10.1002/smll.201201173 · DOI
  20. Wu, 2016, Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA–TPGS for the treatment of liver cancer, Mater. Sci. Eng. C, 59, 792, 10.1016/j.msec.2015.10.087 · DOI
  21. Das, 2019, Preparation of albumin nanoparticles: optimum size for cellular uptake of entrapped drug (Curcumin), Colloid. Surface. Physicochem. Eng. Aspect., 567, 86, 10.1016/j.colsurfa.2019.01.043 · DOI
  22. Zheng, 2016, The effect of particle shape and size on cellular uptake, Drug Deliv. Transl. Res., 6, 67, 10.1007/s13346-015-0270-y · DOI
  23. Bremmell, 2019, Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges, Drug Dev. Ind. Pharm., 45, 349, 10.1080/03639045.2018.1542709 · DOI
  24. Azimullah, 2019, Nanosuspensions as a promising approach to enhance bioavailability of poorly soluble drugs: an update, J. Drug Deliv. Ther., 9, 574, 10.22270/jddt.v9i2.2436 · DOI
  25. Karim, 2019, Strontium sulfite: a new pH-responsive inorganic nanocarrier to deliver therapeutic siRNAs to cancer cells, Pharmaceutics, 11, 89, 10.3390/pharmaceutics11020089 · DOI
  26. Liu, 2013, NIR‐Triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene‐modified mesoporous silica, Angew. Chem. Int. Ed., 52, 4375, 10.1002/anie.201300183 · DOI
  27. Mitchell, 2020, Engineering precision nanoparticles for drug delivery, Nat. Rev. Drug Discov., 1
  28. Chou, 2011, Strategies for the intracellular delivery of nanoparticles, Chem. Soc. Rev., 40, 233, 10.1039/C0CS00003E · DOI
  29. She, 2013, Dendronized heparin− doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy, Biomaterials, 34, 2252, 10.1016/j.biomaterials.2012.12.017 · DOI
  30. Pan, 2013, Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles, Biomaterials, 34, 2719, 10.1016/j.biomaterials.2012.12.040 · DOI
  31. Yamala, 2020, P‐LME polymer nanocapsules stimulate naïve macrophages and protect them from oxidative damage during controlled drug release, J. Appl. Polym. Sci., 137, 48363, 10.1002/app.48363 · DOI
  32. Chen, 2013, Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly (lactic-co-glycolic acid), Int. J. Nanomed., 8, 4315
  33. Ahmadi, 2015, Encapsulation in PLGA-PEG enhances 9-nitro-camptothecin cytotoxicity to human ovarian carcinoma cell line through apoptosis pathway, Res. Pharm. Sci., 10, 161
  34. Parhizkar, 2016, Electrohydrodynamic encapsulation of cisplatin in poly (lactic-co-glycolic acid) nanoparticles for controlled drug delivery, Nanomedicine: NBM (NMR Biomed.), 12, 1919, 10.1016/j.nano.2016.05.005 · DOI
  35. Wang, 2011, Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles, Biomaterials, 32, 8281, 10.1016/j.biomaterials.2011.07.032 · DOI
  36. Esmaeili, 2015, Preparation and characterization of estradiol-loaded PLGA nanoparticles using homogenization-solvent diffusion method, DARU J. Pharm. Sci., 16, 196
  37. Park, 2009, PEGylated PLGA nanoparticles for the improved delivery of doxorubicin, Nanomedicine: NBM (NMR Biomed.), 5, 410, 10.1016/j.nano.2009.02.002 · DOI
  38. Duse, 2019, Photodynamic therapy of ovarian carcinoma cells with curcumin-loaded biodegradable polymeric nanoparticles, Pharmaceutics, 11, 282, 10.3390/pharmaceutics11060282 · DOI
  39. Rehman, 2020, Myricetin abrogates cisplatin-induced oxidative stress, inflammatory response, and goblet cell disintegration in colon of wistar rats, Plants, 9, 28, 10.3390/plants9010028 · DOI
  40. Wohlfart, 2011, Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers, PloS One, 6, 10.1371/journal.pone.0019121 · DOI
  41. Geldenhuys, 2011, Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers, J. Drug Target., 19, 837, 10.3109/1061186X.2011.589435 · DOI
  42. Liu, 2008, Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles, Arch Pharm. Res. (Seoul), 31, 547, 10.1007/s12272-001-1191-8 · DOI
  43. Xia, 2012, Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery, Int. J. Pharm., 436, 840, 10.1016/j.ijpharm.2012.07.029 · DOI
  44. Hu, 2011, Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease, Int. J. Pharm., 415, 273, 10.1016/j.ijpharm.2011.05.062 · DOI
  45. Liu, 2013, Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration, Biomaterials, 34, 3870, 10.1016/j.biomaterials.2013.02.003 · DOI
  46. Liu, 2013, B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide, Bioconjug, Inside Chem., 24, 997
  47. Casettari, 2014, Chitosan in nasal delivery systems for therapeutic drugs, J. Contr. Release, 190, 189, 10.1016/j.jconrel.2014.05.003 · DOI
  48. Wang, 2010, Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain, Biomaterials, 5, 908, 10.1016/j.biomaterials.2009.09.104 · DOI
  49. Trapani, 2011, Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery, Int. J. Pharm., 419, 296, 10.1016/j.ijpharm.2011.07.036 · DOI · Paper page
  50. Park, 2015, Enhanced BBB permeability of osmotically active poly (mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease, Biomaterials, 38, 61, 10.1016/j.biomaterials.2014.10.068 · DOI
  51. Sulheim, 2016, Cellular uptake and intracellular degradation of poly (alkyl cyanoacrylate) nanoparticles, J. Nanobiotechnol., 14, 1, 10.1186/s12951-015-0156-7 · DOI
  52. Lübbe, 1996, Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors, Canc. Res., 56, 4686
  53. Chorny, 2010, Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles, J. Contr. Release, 146, 144, 10.1016/j.jconrel.2010.05.003 · DOI
  54. Child, 2011, Working together: the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3D, ACS Nano, 5, 7910, 10.1021/nn202163v · DOI
  55. Fantechi, 2014, A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages, ACS Nano, 8, 4705, 10.1021/nn500454n · DOI
  56. Mody, 2014, Magnetic nanoparticle drug delivery systems for targeting tumor, Appl. Nanosci., 4, 385, 10.1007/s13204-013-0216-y · DOI
  57. Yuan, 2011, One-dimensional magnetic inorganic–organic hybrid nanomaterials, Chem. Soc. Rev., 40, 640, 10.1039/c0cs00087f · DOI
  58. Zhang, 2014, Assembly of polyethylenimine-functionalized iron oxide nanoparticles as agents for DNA transfection with magnetofection technique, J. Mater. Chem. B., 2, 7936, 10.1039/C4TB01577K · DOI
  59. Chen, 2010, Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe 3 O 4 nanoparticle cores and a PEG-functionalized porous silica shell, Chem. Commun., 46, 8633, 10.1039/c0cc02577a · DOI
  60. Anirudhan, 2020, Temperature and pH sensitive multi-functional magnetic nanocomposite for the controlled delivery of 5-fluorouracil, an anticancer drug, J. Drug Deliv. Sci. Technol., 55, 101476, 10.1016/j.jddst.2019.101476 · DOI
  61. Amin, 2020, Magnetic nanoparticles-a promising tool for targeted drug delivery system, Asian J. Nanosci. Mater., 3, 24
  62. Wu, 2019, Magnetic nanoparticles in nanomedicine: a review of recent advances, Nanotechnology, 30, 502003, 10.1088/1361-6528/ab4241 · DOI
  63. Dabbagh, 2019, Polyethylene glycol-coated porous magnetic nanoparticles for targeted delivery of chemotherapeutics under magnetic hyperthermia condition, Int. J. Hyperther., 36, 104, 10.1080/02656736.2018.1536809 · DOI
  64. Wang, 2014, Magnetic nanoparticles with a pH-sheddable layer for antitumor drug delivery, Colloids Surf. B Biointerfaces, 118, 218, 10.1016/j.colsurfb.2014.04.001 · DOI
  65. Jain, 2005, Iron oxide nanoparticles for sustained delivery of anticancer agents, Mol. Pharm., 2, 194, 10.1021/mp0500014 · DOI
  66. Amani, 2019, Multifunctional magnetic nanoparticles for controlled release of anticancer drug, breast cancer cell targeting, MRI/fluorescence imaging, and anticancer drug delivery, J. Drug Deliv. Sci. Technol., 49, 534, 10.1016/j.jddst.2018.12.034 · DOI
  67. Xie, 2019, Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for targeted drug delivery and photothermal therapy, Colloids Surf. B Biointerfaces, 176, 462, 10.1016/j.colsurfb.2019.01.028 · DOI
  68. Chiniforoshan, 2014, Anti-inflammatory drugs interacting with Zn (II) metal ion based on thiocyanate and azide ligands: synthesis, spectroscopic studies, DFT calculations and antibacterial assays, Spectrochim. Acta: Mol. Biomol. Spectrosc., 128, 183, 10.1016/j.saa.2014.02.135 · DOI
  69. Li, 2014, Controlled release of liposome-encapsulated Naproxen from core-sheath electrospun nanofibers, Carbohydr. Polym., 111, 18, 10.1016/j.carbpol.2014.04.017 · DOI
  70. Georgiadou, 2016, Octadecylamine-mediated versatile coating of CoFe2O4 NPs for the sustained release of anti-inflammatory drug naproxen and in vivo target selectivity, ACS Appl. Mater. Interfaces, 8, 9345, 10.1021/acsami.6b00408 · DOI
  71. Liu, 2010, Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain, Proc. Natl. Acad. Sci. Unit. States Am., 107, 15205, 10.1073/pnas.1003388107 · DOI
  72. Nair, 2013, Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers, Nat. Commun., 4, 1
  73. Qiao, 2012, Receptor-mediated delivery of magnetic nanoparticles across the blood–brain barrier, ACS Nano, 6, 3304, 10.1021/nn300240p · DOI
  74. Ku, 2010, The blood–brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain, Biochem. Biophys. Res. Commun., 394, 871, 10.1016/j.bbrc.2010.03.006 · DOI
  75. Bhattacharya, 2012, Gold nanoparticles conjugated antibiotics: stability and functional evaluation, Nanosci. Nanotechnol., 2, 14, 10.5923/j.nn.20120202.04 · DOI
  76. Murawala, 2014, In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug Methotrexate to MCF-7 breast cancer cells, Mater. Sci. Eng. C, 34, 158, 10.1016/j.msec.2013.09.004 · DOI
  77. Burygin, 2009, On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles, Nanoscale Res. Lett., 4, 794, 10.1007/s11671-009-9316-8 · DOI
  78. Kolate, 2014, PEG—a versatile conjugating ligand for drugs and drug delivery systems, J. Contr. Release, 192, 67, 10.1016/j.jconrel.2014.06.046 · DOI
  79. Panda, 2014, Short peptide based self-assembled nanostructures: implications in drug delivery and tissue engineering, Polym. Chem., 5, 4418, 10.1039/C4PY00173G · DOI
  80. Huang, 2010, Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery, Biomaterials, 31, 9086, 10.1016/j.biomaterials.2010.08.046 · DOI
  81. Lajunen, 2015, Light induced cytosolic drug delivery from liposomes with gold nanoparticles, J. Contr. Release, 203, 85, 10.1016/j.jconrel.2015.02.028 · DOI
  82. Rosi, 2006, Oligonucleotide-modified gold nanoparticles for intracellular gene regulation, Science, 5776, 1027, 10.1126/science.1125559 · DOI
  83. Giljohann, 2009, Gene regulation with polyvalent siRNA−nanoparticle conjugates, J. Am. Chem. Soc., 131, 2072, 10.1021/ja808719p · DOI
  84. Patel, 2008, Peptide antisense nanoparticles, Proc. Natl. Acad. Sci. Unit. States Am., 105, 17222, 10.1073/pnas.0801609105 · DOI
  85. Etame, 2011, Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature, Nanomedicine: NBM (NMR Biomed.), 7, 992, 10.1016/j.nano.2011.04.004 · DOI
  86. Prades, 2012, Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor, Biomaterials, 33, 7194, 10.1016/j.biomaterials.2012.06.063 · DOI
  87. Joh, 2013, Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization, PloS One, 8, 10.1371/journal.pone.0062425 · DOI
  88. Shilo, 2014, Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications, Nanoscale, 6, 2146, 10.1039/C3NR04878K · DOI
  89. Wang, 2009, Ordered mesoporous materials for drug delivery, Microporous Mesoporous Mater., 117, 1, 10.1016/j.micromeso.2008.07.002 · DOI
  90. Tang, 2012, Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery, Adv. Mater., 24, 1504, 10.1002/adma.201104763 · DOI
  91. Yuan, 2019, Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery, J. Colloid Interface Sci., 555, 82, 10.1016/j.jcis.2019.07.061 · DOI
  92. Li, 2019, Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery, Expet Opin. Drug Deliv., 16, 219, 10.1080/17425247.2019.1575806 · DOI
  93. Siminzar, 2020, Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer, J. Drug Target., 28, 92, 10.1080/1061186X.2019.1616745 · DOI
  94. Rosenholm, 2010, Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles–opportunities & challenges, Nanoscale, 2, 1870, 10.1039/c0nr00156b · DOI
  95. Ashley, 2011, The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers, Nat. Mater., 10, 389, 10.1038/nmat2992 · DOI
  96. Zhang, 2014, Composite of functional mesoporous silica and DNA: an enzyme-responsive controlled release drug carrier system, ACS Appl. Mater. Interfaces, 6, 8042, 10.1021/am502154w · DOI
  97. Manzano, 2020, Mesoporous silica nanoparticles for drug delivery, Adv. Funct. Mater., 30, 1902634, 10.1002/adfm.201902634 · DOI
  98. Popat, 2012, A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles, J. Mater. Chem., 22, 11173, 10.1039/c2jm30501a · DOI
  99. Muhammad, 2011, pH-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids, J. Am. Chem. Soc., 133, 8778, 10.1021/ja200328s · DOI
  100. Luo, 2011, Mesoporous silica nanoparticles end‐capped with collagen: redox‐responsive nanoreservoirs for targeted drug delivery, Angew. Chem. Int. Ed., 50, 640, 10.1002/anie.201005061 · DOI
  101. Liu, 2008, Tunable redox-responsive hybrid nanogated ensembles, J. Am. Chem. Soc., 130, 14418, 10.1021/ja8060886 · DOI
  102. Kim, 2010, Glutathione‐induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers, Adv. Mater., 22, 4280, 10.1002/adma.201001417 · DOI
  103. Xu, 2016, Synthesis and characterization of a poly (amido amine) modified magnetic nanocarrier for controlled delivery of doxorubicin, J. Nanosci. Nanotechnol., 16, 1363, 10.1166/jnn.2016.10697 · DOI
  104. Gao, 2016, Fe 3 O 4@ mSiO 2-FA-CuS-PEG nanocomposites for magnetic resonance imaging and targeted chemo-photothermal synergistic therapy of cancer cells, Dalton Trans., 45, 13456, 10.1039/C6DT01714B · DOI
  105. Song, 2014, Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors, Oncol. Rep., 32, 1481, 10.3892/or.2014.3344 · DOI
  106. Fu, 2016, Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery, Nanomedicine: NBM (NMR Biomed.), 12, 1951, 10.1016/j.nano.2016.04.013 · DOI
  107. Wang, 2016, A multifunctional poly (curcumin) nanomedicine for dual-modal targeted delivery, intracellular responsive release, dual-drug treatment and imaging of multidrug resistant cancer cells, J. Mater. Chem. B., 4, 2954, 10.1039/C5TB02450A · DOI
  108. Chowdhuri, 2016, Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agent, Dalton Trans., 45, 2963, 10.1039/C5DT03736K · DOI
  109. Sarika, 2016, Polyelectrolyte complex nanoparticles from cationised gelatin and sodium alginate for curcumin delivery, Carbohydr. Polym., 148, 354, 10.1016/j.carbpol.2016.04.073 · DOI
  110. Lian, 2016, Synthesis and characterization of curcumin-functionalized HP-β-CD-Modified GoldMag nanoparticles as drug delivery agents, J. Nanosci. Nanotechnol., 16, 6258, 10.1166/jnn.2016.11370 · DOI
  111. Ma'mani, 2014, Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy, Eur. J. Med. Chem., 83, 646, 10.1016/j.ejmech.2014.06.069 · DOI
  112. Rafi, 2016, Eur. J. Pharmaceut. Sci., 93, 64, 10.1016/j.ejps.2016.08.005 · DOI
  113. Alidadiyani, 2016, Synergistic antiproliferative effects of methotrexate-loaded smart silica nanocomposites in MDA-MB-231 breast cancer cells, Artificial cells, Nanomed, Biotechnol., 44, 603
  114. Bessar, 2016, Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis, Colloids Surf. B Biointerfaces, 141, 141, 10.1016/j.colsurfb.2016.01.021 · DOI
  115. Farjadian, 2016, Hydroxyl-modified magnetite nanoparticles as novel carrier for delivery of methotrexate, Int. J. Pharm., 504, 110, 10.1016/j.ijpharm.2016.03.022 · DOI

Cited by

Sorted by citations

See all 161

Metadata

Authors
Shah, A., Aftab, S., Nisar, J., Ashiq, M. N., & Iftikhar, F. J.
ORCID
Iftikhar, Faiza Jan
Venue
Journal of Drug Delivery Science and Technology
Publisher
Elsevier BV
Published
2021-04
Volume
62
Pages
102426
ISSN
1773-2247
DOI
10.1016/j.jddst.2021.102426
Cited by
161
References
3
Language
en
Licence
Funders
Higher Education Commision, Pakistan (20-/3070/NRPU/R&D/HEC/14)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review